AlgoTherapeutix
Latest round
- Series B
Last raised
- Mar 2023
Total raised
- $29M
Investors
- 5
About AlgoTherapeutix
AlgoTherapeutix SAS, founded in 2018 and headquartered in Suresnes, France, specializes in developing non-opioid treatments for pain.AlgoTherapeutix SAS specializes in developing innovative, non-opioid therapies for complex pain conditions, particularly targeting Chemotherapy-Induced Peripheral Neuropathy (CIPN). Their flagship product, ATX01, is currently in Phase 2 clinical development and is designed to alleviate CIPN pain by inhibiting specific nociceptive sodium channels.AlgoTherapeutix SAS generates revenue through partnerships with healthcare professionals and institutions, providing treatments for pain conditions. The company aims to expand its market presence in the United States and Europe by continuing to develop and launch new products tailored for patients with difficult-to-treat pain conditions.
Who invested in AlgoTherapeutix
5 investors across 2 rounds
See all investors in AlgoTherapeutix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AlgoTherapeutix
Who invested in AlgoTherapeutix?
AlgoTherapeutix has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AlgoTherapeutix raised?
AlgoTherapeutix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AlgoTherapeutix last raise money?
AlgoTherapeutix's most recent round on record is a Series B, in Mar 2023.
What does AlgoTherapeutix do?
AlgoTherapeutix SAS, founded in 2018 and headquartered in Suresnes, France, specializes in developing non-opioid treatments for pain.
Where is AlgoTherapeutix headquartered?
AlgoTherapeutix is headquartered in Suresnes, France.
Which VCs invest in companies like AlgoTherapeutix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at AlgoTherapeutix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like AlgoTherapeutix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.